Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
These treatments are not just about weight, they are proven tools to reduce chronic disease, lower long-term healthcare costs, and improve quality of life for thousands of Ohioans
Wegovy (Semaglutide for Chronic Weight Management) FDA indication: Chronic weight management in adults with BMI 30 or greater, or BMI 27 or greater with at least one weight-related comorbidity Approved doses: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg (weekly subcutaneous injection) Target maintenance dose: 2.4 mg weekly Pediatric indication: Approved for adolescents aged 12 and older with obesity Ozempic (Semaglutide for Type 2 Diabetes) FDA indication: Adjunct to diet and exercise for glycemic control in adults with type 2 diabetes Approved doses: 0.25 mg, 0.5 mg, 1.0 mg, 2.0 mg (weekly subcutaneous injection) Note: Not FDA-approved for weight management, though frequently prescribed off-label Rybelsus (Oral Semaglutide) FDA indication: Type 2 diabetes management Doses: 3 mg, 7 mg, 14 mg (daily oral tablet) Lower bioavailability: Oral formulation has approximately 1% bioavailability, resulting in less predictable weight loss compared to injectable forms Comprehensive semaglutide training for physicians emphasizes the importance of prescribing the correct formulation for the correct indication
Improves Gut Health A balanced gut microbiome improves digestion , combats bloating, and enhances nutrient absorption, creating the perfect environment for weight loss
Some studies suggest that L-carnitine could have neuroprotective effects and support cognitive function
however, there is little information on effects on other pancreatic tissues that might be involved in inflammatory processes
When elevated B12 is detected, confirmation with repeat testing is advisable
US$ 21.77
US$ 25.52
US$ 27.65
